Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/24/12 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 | |
| 09/20/12 | 8-K | Current report filing |
|
5 | |
| 09/18/12 | 8-K | Current report filing |
|
5 | |
| 09/18/12 | UPLOAD | SEC-generated letter |
|
2 | |
| 09/14/12 | 8-K | Current report filing |
|
5 | |
| 09/10/12 | 8-K | Current report filing |
|
3 | |
| 08/23/12 | 8-K | Current report filing |
|
18 | |
| 08/13/12 | 8-K | Current report filing |
|
14 | |
| 08/13/12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
39 |
| 08/02/12 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
|
2 |
